LB

Laurence Boumsell

CN CNRS: 1 patents #3,857 of 11,908Top 35%
DI Dana-Farber Cancer Institute: 1 patents #698 of 1,343Top 55%
UO Universite De Bretagne Occidentale: 1 patents #30 of 142Top 25%
Overall (All Time): #515,392 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
8679500 Compositions containing antibodies for treating CD5+ HLA-DR+ B or T cell related diseases Christian Berthou, Karine Lester, Severine Loisel, Martine Cerruti 2014-03-25
8518655 Means for the diagnosis and therapy of CTCL Armand Bensussan, Martine Bagot, Allessandro Moretta 2013-08-27
8444978 Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2 Armand Bensussan, Phillipe Le Bouteiller 2013-05-21
8409573 Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells Jean Kadouche, Armand Bensussan 2013-04-02
8268308 Means for the diagnosis and therapy of CTCL Armand Bensussan, Martine Bagot, Allessandro Moretta 2012-09-18
8067247 Use of anti-CD100 antibodies for the treatment of inflammatory disorders affecting the central or peripheral nervous system Marie-Francoise Belin, Pascale Giraudon, Armand Bensussan 2011-11-29
7919085 Means for the diagnosis and therapy of CTCL Armand Bensussan, Martine Bagot, Allessandro Moretta 2011-04-05
7736647 Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells Armand Bensussan, Jean Kadouche 2010-06-15
7700102 Nucleic acids encoding CD100 molecules Kathryn T. Hall, Gordon J. Freeman, Joachim L. Schultze, Vassiliki Boussiotis, Lee M. Nadler +1 more 2010-04-20
7399595 Means for the diagnosis and therapy of CTCL Armand Bensussan, Martine Bagot, Allessandro Moretta 2008-07-15